In vitro bactericidal activity of the glycopeptide compounds vancomycin, teicoplanin and ramoplanin (A-16686/MDL 62,198).
O'Hare
M D
MD
Department of Clinical Microbiology, University College Hospital, Gower Street, London, UK.
Felmingham
D
D
Grüneberg
R N
RN
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D003013:Clostridium / Q000187:drug effects; D003352:Corynebacterium / Q000187:drug effects; D047630:Depsipeptides / Q000494:pharmacology*; D006020:Glycopeptides / Q000494:pharmacology; D006801:Humans; D008826:Microbial Sensitivity Tests; D010462:Peptostreptococcus / Q000187:drug effects; D011425:Propionibacterium acnes / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D017334:Teicoplanin / Q000494:pharmacology*; D014640:Vancomycin / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D047630:Depsipeptides; D006020:Glycopeptides; C041438:ramoplanin; D017334:Teicoplanin; D014640:Vancomycin